Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis

Completed · Phase 1 · Has a placebo group

Conditions studied: Diabetes Mellitus Type 1 and 2, Diabetes Mellitus Complications, Gastroparesis, Gastrointestinal Motility Disorder

In brief

The purpose of this study is to evaluate the pharmacodynamic (PD) and pharmacokinetic (PK) profile and the safety and tolerability of RM-131 in patients with diabetes mellitus and delayed gastric emptying.

Key facts

Study ID

NCT01394055

Run by

Motus Therapeutics, Inc.

People needed

20

Starts

2011-07-01

Expected to finish

2012-12-01

Last updated by the study team

2016-09-22

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.